PH25585A - Method for the treatment of osteoporosis, related disorders - Google Patents

Method for the treatment of osteoporosis, related disorders

Info

Publication number: PH25585A
Authority: PH; Philippines
Prior art keywords: malate; calcium citrate; osteoporosis; treatment; citrate malate
Prior art date: 1987-08-28

Application number

PH37460A

Other languages

English (en)

Inventor

Barbara Ann Kochanowski

Original Assignee

Barbara Ann Kochanowski

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-08-28

Filing date

1988-08-26

Publication date

1991-08-08

1988-08-26 Application filed by Barbara Ann Kochanowski filed Critical Barbara Ann Kochanowski

1991-08-08 Publication of PH25585A publication Critical patent/PH25585A/en

Links

208000001132 Osteoporosis Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
208000035475 disorder Diseases 0.000 title 1
229940092124 calcium citrate malate Drugs 0.000 abstract 4
MPCMQXRREZMSPJ-UHFFFAOYSA-L calcium;2-hydroxybutanedioate;2-hydroxypropane-1,2,3-tricarboxylic acid;pentahydrate Chemical compound O.O.O.O.O.[Ca+2].[O-]C(=O)C(O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MPCMQXRREZMSPJ-UHFFFAOYSA-L 0.000 abstract 4
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
210000000988 bone and bone Anatomy 0.000 abstract 1
159000000007 calcium salts Chemical class 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
229940049920 malate Drugs 0.000 abstract 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000006186 oral dosage form Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Non-Alcoholic Beverages (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

PH37460A 1987-08-28 1988-08-26 Method for the treatment of osteoporosis, related disorders PH25585A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9100687A	1987-08-28	1987-08-28

Publications (1)

Publication Number	Publication Date
PH25585A true PH25585A (en)	1991-08-08

Family

ID=22225323

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH37460A PH25585A (en)	1987-08-28	1988-08-26	Method for the treatment of osteoporosis, related disorders

Country Status (9)

Country	Link
EP (1)	EP0304986B1 (de)
JP (1)	JP2738541B2 (de)
KR (1)	KR970009582B1 (de)
AT (1)	ATE88633T1 (de)
CA (1)	CA1329774C (de)
DE (1)	DE3880587T2 (de)
HK (1)	HK94096A (de)
IE (1)	IE61451B1 (de)
PH (1)	PH25585A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5108761A (en) *	1990-10-01	1992-04-28	The Procter & Gamble Company	Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium
JPH06502310A (ja) *	1990-10-31	1994-03-17	ザ、プロクター、エンド、ギャンブル、カンパニー	カルシウム強化ソース
WO1993012672A1 (en) *	1991-12-26	1993-07-08	The Procter & Gamble Company	Storage stable calcium-supplemented beverage concentrates
US5389387A (en) *	1991-12-26	1995-02-14	The Procter & Gamble Company	Storage stable calcium-supplemented beverage concentrates
AU4597293A (en) *	1992-06-30	1994-01-24	Procter & Gamble Company, The	Effervescent calcium supplements
WO1994008472A1 (en) *	1992-10-21	1994-04-28	The Procter & Gamble Company	Concentrated bioavailable calcium source
ATE140125T1 (de) *	1992-10-21	1996-07-15	Procter & Gamble	Lagerfähige, kalziumzusatzenthaltende getränkekonzentrate und sirup
EP0665719B1 (de) *	1992-10-21	1997-01-15	The Procter & Gamble Company	Eine konzentrierte lebensverfügbare kalziumsquelle enthaltender süssstof
IT1256300B (it) *	1992-11-05	1995-11-29	Dompe Farmaceutici Spa	Uso di acidi aril-, eteroaril- e alchiltartronici come agenti terapeutici
BR9914079A (pt) *	1998-09-29	2001-06-19	Procter & Gamble	Bebidas de baixa acidez suplementadas com fontes de cálcio nutricionais
US6811800B2 (en)	1998-09-29	2004-11-02	The Procter & Gamble Co.	Calcium fortified beverages
CN101505730B (zh) *	2006-08-17	2013-02-13	宝洁公司	包含柠檬酸苹果酸钙的组合物以及它们的制备方法
TR200908237A2 (tr)	2009-11-02	2011-05-23	Bi̇lgi̇ç Mahmut	Kalsiyum ve D vitamini içeren farmasötik bileşimler.
EP2685973A1 (de)	2011-03-16	2014-01-22	The Charlotte-Mecklenburg Hospital Authority D/B/A	Zusammensetzungen und verfahren zur behandlung von muskelskeletterkrankungen und erkrankungen unter verwendung von ionen-citrat-analoga-komplexen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5697248A (en) *	1979-12-28	1981-08-05	Tanaka Shiro	Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) *	1986-07-09	1988-01-15	Sandoz Lab	Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) *	1987-07-02	1988-11-22	The Procter & Gamble Company	Calcium-iron mineral supplements

1988
- 1988-08-15 AT AT88201733T patent/ATE88633T1/de not_active IP Right Cessation
- 1988-08-15 EP EP88201733A patent/EP0304986B1/de not_active Expired - Lifetime
- 1988-08-15 DE DE8888201733T patent/DE3880587T2/de not_active Expired - Lifetime
- 1988-08-25 CA CA000575678A patent/CA1329774C/en not_active Expired - Lifetime
- 1988-08-26 KR KR88010858A patent/KR970009582B1/ko not_active Expired - Lifetime
- 1988-08-26 IE IE260988A patent/IE61451B1/en not_active IP Right Cessation
- 1988-08-26 PH PH37460A patent/PH25585A/en unknown
- 1988-08-27 JP JP63213488A patent/JP2738541B2/ja not_active Expired - Lifetime
1996
- 1996-05-30 HK HK94096A patent/HK94096A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA1329774C (en)	1994-05-24
EP0304986A2 (de)	1989-03-01
JP2738541B2 (ja)	1998-04-08
EP0304986A3 (en)	1990-03-07
HK94096A (en)	1996-06-07
KR970009582B1 (en)	1997-06-14
JPH01151515A (ja)	1989-06-14
IE882609L (en)	1989-02-28
IE61451B1 (en)	1994-11-02
ATE88633T1 (de)	1993-05-15
DE3880587D1 (de)	1993-06-03
DE3880587T2 (de)	1993-09-23
KR890003390A (ko)	1989-04-14
EP0304986B1 (de)	1993-04-28

Similar Documents

Publication	Publication Date	Title
KR970009582B1 (en)	1997-06-14	Method for the treatment of oste oporosis and related disorders
RU98111594A (ru)	2000-05-20	Фармацевтические композиции, включающие флурбипрофен
ATE130762T1 (de)	1995-12-15	Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
ATE204178T1 (de)	2001-09-15	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
IL113651A0 (en)	1995-08-31	Pharmaceutical compositions containing alendronate and their use
IL92269A0 (en)	1990-07-26	Pharmaceutical composition for treatment of autoimmune diseases
ATE289199T1 (de)	2005-03-15	Formulierungen mit dem wasserfreien mononatriumsalz von alendronat und deren verwendung zur behandlung von knochenkrankheiten
ATE71629T1 (de)	1992-02-15	Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
IL87452A (en)	1992-07-15	Calcium citrate malate and calcium supplements containing it
GB2235626B (en)	1994-02-09	Inhalation medicaments for treating respiratory disorders
DK0668077T3 (da)	2001-10-08	Produkter, som indeholder G-CSF og TNF-bindende protein
ATE133859T1 (de)	1996-02-15	Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
DK164441C (da)	1992-11-09	Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
DE3685853D1 (de)	1992-08-06	Mittel zur behandlung von knochenkrankheiten.
DE69420776D1 (de)	1999-10-28	Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE68919673D1 (de)	1995-01-12	Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse.
DE69315162D1 (de)	1997-12-18	Verwendung von L-Carnitine und Acyl-L-Carnitinen zur Behandlung von Patienten die an AIDS-verwandten Syndromen leiden und von asymptomatischen HIV-seropositiven Patienten
DE69223455D1 (de)	1998-01-22	WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
EP0612246A4 (de)	1995-04-19	Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen.
DE3879489D1 (de)	1993-04-22	Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
FR2635006B1 (fr)	1990-10-19	Medicament destine a regulariser les secretions hormonales et a traiter la sterilite